Effects of PI3-k/Akt short hairpin RNA on proliferation, fibronectin production and synthesis of thrombospondin-1 and transforming growth factor-β1 in glomerular mesangial cells induced by sublytic C5b-9 complexes

Cell Proliferation

Volumn 42, Issue 1, 2009, Pages 83-93

  Gao, L ^a   Zhang, Y ^a   Qiu, W ^a   Xu, W ^a   Feng, X ^a   Ren, J ^a   Jiang, X ^a   Wang, H ^a   Zhao, D ^a   Wang, Y ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5B; COMPLEMENT COMPONENT C9; CYCLIN D2; FIBRONECTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SHORT HAIRPIN RNA; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; MESANGIUM CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL PROLIFERATION; COMPLEMENT C5B; COMPLEMENT C9; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRONECTINS; GLOMERULAR MESANGIUM; PLASMIDS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RNA; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 58449087668     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2008.00575.x     Document Type: Article

References (51)

1. Alpers CE, Hudkins KL, Gown AM, Johnson RJ (1992) Enhanced expression of 'muscle-specific' actin in glomerulonephritis. Kidney Int. 41, 1134 1144.
2. 2 and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. Kidney Int. 70, 1251 1260.
3. Couser WG, Pippin JW, Shankland SJ (2001) Complement (C5b-9) induces DNA synthesis in rat GMCs in vitro. Kidney Int. 59, 905 912.
4. Bessho K, Mizuno S, Matsumoto K (2003) Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis. Am. J. Physiol. Renal Physiol. 284, F1171 F1180.
5. Wu SH, Wu XH, Lu C, Dong L, Zhou GP, Chen ZQ (2006) Lipoxin A4 inhibits connective tissue growth factor-induced production of chemokines in rat mesangial cells. Kidney Int. 69, 248 256.
6. Brandt J, Pippin J, Schulze M, Hansch GM, Alpers CE, Johnson RJ, Gordon K, Couser WG (1996) Role of the complement membrane attack complex (C5b-9) in mediating experimental mesangioproliferative glomerulonephritis. Kidney Int. 49, 335 343.
7. Wang YW, He QZ, Qin HL, Xu JH, Tong JX, Gao LJ, Xu J (2006) The complement C5b-9 complexes induced injury of glomerular mesangial cells in rats with Thy-1 nephritis by increasing nitric oxide synthesis. Life Sci. 79, 182 192.
8. Okamoto M, Ono M, Uchiumi T, Ueno H, Kohno K, Sugimachi K, Kuwano M (2002) Up-regulation of thrombospondin-1 gene by epidermal growth factor and transforming growth factor (in human cancer cells - transcriptional activation and messenger RNA stabilization. Biochim. Biophys. Acta. 1574, 24 34.
9. Gao LJ, Qiu W, Wang YW, Xu WH, Xu J, Tong JX (2006) Sublytic complement C5b-9 complexes induce thrombospondin-1 production in rat glomerular mesangial cells via PI3-k/Akt: association with activation of latent transforming growth factor-β1. Clin. Exp. Immuol. 144, 326 334.
10. Yamamoto T, Wilson CB (1987) Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int. 32, 514 525.
11. Adams JC (1997) Thrombospondin-1. Int. J Biochem. Cell Biol. 29, 861 865.
12. Munger JS, Harpel JG, Gleizes PE, Mazzieri R, Nunes I, Rifkin DB (1997) Latent transforming growth factor-β: Structural features and mechanisms of activation. Kidney Int. 51, 1376 1382.
13. Krishnaswami S, Ly QP, Rothman VL, Tuszynski GP (2002) Thrombospondin-1 promotes proliferative healing through stabilization of PDGF. J. Surq. Res. 107, 124 130.
14. 1 in human mesangial cells exposed to high glucose. J. Am. Soc. Nephrol. 12, 703 712.
15. Cheng J, Grande JP (2002) Transforming growth factor-β signal transduction and progressive renal disease. Exp Biol. Med. 227, 943 956.
16. Liu X, Hu H, Yin JO (2006) Therapeutic strategies against TGF-β signaling pathway in hepatic fibrosis. Liver Int. 26, 8 22.
17. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME (1999) Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857 868.
18. Lubna AK, Karim B, Stephan G, Fredrik L (2006) Signaling specificity of interleukin-6 action on glucose and lipid metabolism in skeletal muscle. Mol. Endocrinol. 36, 79 83.
19. Stein RC, Waterfield MD (2000) PI3-kinase inhibition: a target for drug development. Mol. Med. Today 6, 347 357.
20. Vazquez. F, Sellers W (2000) The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling. Biochim. Biophys. Acta 1470, M21 M35.
21. Roymans D, Slegers H (2001) Phosphatidylinositol 3-kinases in tumor progression. Eur J. Biochem. 268, 487 498.
22. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806 811.
23. Dykxhoorn DM, Novina CD, Sharp PA (2003) Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 4, 457 467.
24. Mello CC, Conte D Jr (2004) Revealing the world of RNA interference. Nature 431, 338 342.
25. Meister G, Tuschl T (2004) Mechanisms of gene silencing by double-stranded RNA. Nature 431, 343 349.
26. Yamamoto T, Wilson CB (1987) Complement dependence of antibody-induced mesangial cell injury in the rat. J. Immunol. 138, 3758 3765.
27. Kuo HT, Shin SJ, Kuo MC, Chen HC (2006) Effects of specific endothelin-1 receptor antagonists on proliferation and fibronectin production of glomerular mesangial cells stimulated with Angiotensin II. Kaohsiung J. Med. Sci. 22, 371 376.
28. Helske S, Oksjoki R, Lindstedt KA, Lommi J, Turto H (2007) Complement system is activated in stenotic aortic valves. Atherosclerosis 9, 2594 2601.
29. Lee HM, Lin DP, Lee DS, Cho J (2007) Role of complement regulatory proteins in the survival of murine allo-transplanted Sertoli cells. J. Korean Med. Sci. 22, 277 282.
30. Shankland SJ, Pippin JW, Couser WG (1999) Complement (C5b-9) induces glomerular epithelial cell DNA synthesis but not proliferation in vitro. Kidney Int. 56, 538 548.
31. Turrnberg D, Cook HT (2005) Complement and glomerulonephritis: new insights. Curr. Opin. Nephrol. Hypertens. 14, 223 228.
32. Rus H, Niculescu F, Badea T, Shin ML (1997) Terminal complement complexes induce cell cycle entry in oligodendrocytes through mitogen activated protein kinase pathway. Immunopharmacology 38, 177 187.
33. Dudek H, Datta SR, Franke TF (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275, 661 665.
34. Soane L, Cho HJ, Niculescu F, Rus H, Shin ML (2001) C5b-9 terminal complement complex protects oligodendrocytes from death by regulating bad through phosphatidylinositol 3-Kinase/Akt pathway. J. Immunol. 167, 2305 2311.
35. Song G, Ouyang GL, Bao SD (2005) The activation of Akt/PKB signaling pathway and cell survival. J. Cell. Mol. Med. 9, 59 71.
36. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKT-ion blocks apoptosis. Cell 88, 435 437.
37. Franke TF (2000) Assays for Akt. Methods Enzymol. 322, 411 410.
38. Takano R, Hisahara S, Namikawa K, Kiyama H, Okano H, Miura M (2000) Nerve growth factor protects oligodendrocytes from tumor necrosis factor-α-induced injury through Akt-mediated signaling mechanisms. J. Biol. Chem. 275, 16360 16365.
39. Niculescu F, Van Rus HBT, Shin ML (1997) Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent. J. Immunol. 158, 4405 4412.
40. Rus HG, Niculescu F, Shin ML (1996) Sublytic complement attack induces cell cycle in oligodendrocytes. J. Immunol. 156, 4892 4900.
41. Shimamura H, Terada Y, Okado T, Tanaka H, Inoshita S, Sasaki S (2003) The PI3-kinase-Akt pathway promotes mesangial cell survival and inhibits apoptosis in vitro via NF-κB and Bad. J. Am. Soc. Nephrol. 14, 1427 1434.
42. Hirko A, Tang F, Hughes JA (2003) Cationic lipid vectors for plasmid DNA delivery. Curr. Med. Chem. 10, 1185 1193.
43. Caplen NJ (2004) Gene therapy progress and prospects. Downregulating gene expression: the impact of RNA interference. Gene Ther. 11, 1241 1248.
44. Lei XY, Zhong M, Feng LF, Yan CY, Zhu BY, Tang SS, Liao DF (2005) Silencing of Bcl-XL expression in human MGC-803 gastric cancer cells by siRNA. Acta Biochim. Biophys. Sin. 37, 555 560.
45. Brummelkamp TR, Bernards R, Agami R. (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science. 296, 550 553.
46. George J, Tsutsumi M (2007) siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in rats. Gene Ther. 1, 1 14.
47. Sui G, Soohoo C, Affarel B, Gay F, Shi Y, Forrester WC, Shi Y (2002) A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99, 5515 5520.
48. Yu JY, Ruiter SL, Turner DL (2002) RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc. Natl Acad. Sci. USA 99, 6047 6052.
49. Fischer JW, Stoll M, Hahn AW, Unger T (2001) Differential regulation of thrombospondin-1 and fibronectin by angiotensin II receptor subtypes in cultured endothelial cells. Cardiovasc. Res. 51, 784 791.
50. Majack RA, Goodman LV, Dixit VM (1988) Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J. Cell Biol. 106, 415 422.
51. Strutz F, Zeisberg M, Renziehausen A, Raschke B, Becker V, Muller G (2001) TGF-β1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int. 59, 579 592.